Claims
- 1. A process for preparing a cephalosporin compound of the formula ##STR83## wherein R.sup.1 represents an alkyl having 1 to 4 carbon atoms, alkenyl having 2 to 6 carbon atoms: phenyl; naphthyl; phenyl substituted on the aromatic ring with one or two lower alkyls, one halogen, nitro or lower alkyloxy; benzyl; naphthylmethyl; phenylmethyl substituted on the phenyl ring with one lower alkyl, halogen, nitro or lower alkyloxy; phenoxymethyl; or phenoxymethyl substituted on the phenyl ring with one lower alkyl, halogen, nitro or lower alkyloxy;
- R.sup.2 represents carboxyl, COOR' or CONHR' wherein R' is methyl, 2,2,2-trichloroethyl, diphenylmethyl, benzyl, p-nitrobenzyl, isobutyl or tert-butyl,
- Y is --SR.sup.4 wherein R.sup.4 is alkyl having 1 to 4 carbon atoms; or phenyl optionally substituted with one lower alkyl, halogen, nitro or lower alkoxy; or an aromatic heterocyclic group selected from the group consisting of ##STR84## wherein R.sup.5 is lower alkyl; said process comprising the steps of
- (1) reacting a thiazolinoazetidinone compound of the formula ##STR85## wherein R.sup.1 and R.sup.2 are as defined above with an alkali metal iodide in a solvent capable of dissolving the compound of the formula (I) and the alkali metal iodide to produce a thiazolinoazetidinone compound of the formula ##STR86## wherein R.sup.1 and R.sup.2 are as defined above; (2) reacting the compound of the formula (VI) with a nucleophilic reagent of the formula
- M--Y (VII)
- wherein M is an alkali metal atom, and Y represents --SR.sup.4 in which R.sup.4 is as defined above in an organic solvent capable of dissolving the compound of the formula (VI) and the nucleophilic reagent of the formula (VII) to give a thiazolinoazetidinone compound of the formula ##STR87## wherein R.sup.1, R.sup.2 and Y are as defined above; (3) reacting the compound of the formula (II) in a water-containing organic solvent having a water content of about 1 to about 500 moles of water per mole of the compound of the formula (II) with a sulfur-containing compound of the formula
- Z--S--X (III)
- wherein Z represents phenyl optionally substituted with three or five halogen atoms or with one nitro group, or Z is 2-pyridyl, 2-benzothiazolyl, 1,3,4-thiadiazole-2-yl or 5-methyl-1,3,4-thiadiazole-2-yl and X represents a halogen atom to produce an azetidinone compound of the formula ##STR88## wherein R.sup.1, R.sup.2, Y and Z are as defined above; and (4) reacting ammonia with the compound of the formula (IV) in an inert aprotic polar solvent so that the compound of the formula (IV) is subjected to ring closure to give the compound of formula (V).
- 2. A process as defined in claim 1 wherein R.sup.4 is selected from the group consisting of ##STR89## phenyl, n-butyl, ##STR90## methyl, p-nitrophenyl, p-chlorophenyl, p-methoxyphenyl, p-tolyl, ##STR91##
- 3. A process as defined in claim 1 wherein R.sup.1 is methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, allyl, butenyl, hexenyl, phenyl, naphthyl, tolyl, xylyl, p-chlorophenyl, p-nitrophenyl, p-methoxyphenyl, benzyl, naphthylmethyl, tolylmethyl, p-chloropphenylmethyl, p-nitrophenylmethyl, p-methoxyphenylmethyl, phenoxymethyl, tolyloxymethyl, p-chlorophenoxymethyl, p-nitrophenoxymethyl or p-methoxyphenoxymethyl.
- 4. A process for preparing a cephalosporin compound of the formula ##STR92## wherein R.sup.1 represents alkyl having 1 to 4 carbon atoms, an alkenyl having 2 to 6 carbon atoms; phenyl; naphthyl; phenyl substituted on the aromatic ring with one or two lower alkyls, one halogen, nitro or lower alkyloxy; benzyl, naphthylmethyl; phenylmethyl substituted on the phenyl ring with one lower alkyl, halogen, nitro or lower alkyloxy; or phenoxymethyl substituted on the phenyl ring with one lower alkyl, halogen, nitro or lower alkyloxy;
- R.sup.2 represents COOR' or CONHR' wherein R' is methyl, 2,2,2-trichloroethyl, diphenylmethyl, benzyl, p-nitrobenzyl, isobutyl or tert-butyl,
- Y is selected from the group consisting of ##STR93## wherein R.sup.3 is alkyl having 1 to 4 carbon atoms which is optionally substituted with one or three halogen; or phenyl optionally substituted with one lower alkyl, halogen, nitro or lower alkoxy,
- said process comprising the steps of
- (1) reacting a thiazolinoazetidinone compound of the formula ##STR94## wherein R.sup.1 and R.sup.2 are as defined above with an alkali metal iodide in a solvent capable of dissolving the compound of the formula (I) and the alkali metal iodide to produce a thiazolinoazetidinone compound of the formula ##STR95## wherein R.sup.1 and R.sup.2 are as defined above; (2) reacting the compound of the formula (VI) either with a nucleophilic reagent of the formula
- M--Y' (VII)
- wherein M is an alkali metal atom, and Y' represents ##STR96## in which R.sup.3 is as defined above in an organic solvent capable of dissolving the compound of the formula (VI) and the nucleophilic reagent of the formula (VII), or with an alkali metal nitrate in an aprotic polar organic solvent to give a thiazolinoazetidinone compound of the formula ##STR97## wherein R.sup.1, R.sup.2 and Y are as defined above; (3) reacting the compound of the formula (II) in a water-containing organic solvent having a water content of about 1 to about 500 moles of water per mole of the compound of the formula (II) with a sulfur-containing compound of the formula
- Z--S--X (III)
- wherein Z is phenyl optionally substituted with three or five halogen atoms or with three or five halogen atoms or with one nitro group, or Z is 2-pyridyl, 2-benzothiazolyl, 1,3,4-thiadiazole-2-yl, 5-methyl-1,3,4-thiadiazole-2-yl and X represents a halogen atom to produce an azetidinone compound of the formula ##STR98## wherein R.sup.1, R.sup.2, Y and Z are as defined above; and (4) reacting ammonia with the compound of the formula (IV) in an inert organic polar solvent so that the compound of the formula (IV) is subjected to ring closure to give the compound of formula (V).
- 5. A process as defined in claim 4 wherein R.sup.1 is methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, allyl, butenyl, hexenyl, phenyl, naphthyl, tolyl, xylyl, p-chlorophenyl, p-nitrophenyl, p-methoxyphenyl, benzyl, naphthylmethyl, tolylmethyl, p-chlorophenylmethyl, p-nitrophenylmethyl, p-methoxyphenylmethyl, phenoxymethyl, tolyloxymethyl, p-chlorophenoxymethyl, p-nitrophenoxymethyl or p-methoxyphenoxymethyl.
Priority Claims (1)
Number |
Date |
Country |
Kind |
57-153569 |
Sep 1982 |
JPX |
|
Parent Case Info
This is a division of application Ser. No. 609,080 filed May 1, 1984, now U.S. Pat. No. 4,665,166, and PCT/JP83/00291 filed Sept. 1, 1983.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4482491 |
Torii |
Nov 1984 |
|
Non-Patent Literature Citations (1)
Entry |
Torii, Tetrahedron Letters 23(24), pp. 2495-2498 (1982). |
Divisions (1)
|
Number |
Date |
Country |
Parent |
609080 |
May 1984 |
|